Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance - Berckmans Y; Ene HM; Ben-Meir K; Martinez-Conde A; Wouters R; Van den Ende B; Van Mechelen S; Monin R; Frechtel-Gerzi R; Gabay H; Dor-On E; Haber A; et al. (Frontiers in Oncology, 2024)
FEMU ID: 55275; EMF-Portal URL: https://www.emf-portal.org/en/article/55275